Kura Oncology Inc. (NASDAQ: KURA) shares rose 11% in pre-market trading on Monday after the company’s President and CEO, Troy Edward Wilson, purchased $1.24 million in company stock.
Wilson acquired 100,000 shares at a weighted average price of $12.39 per share, according to a filing with the U.S. Securities and Exchange Commission. The transaction occurred on August 24, 2026, with prices ranging between $11.47 and $12.85 across multiple trades.
Following the purchase, Wilson’s indirect stake via the One Fish Two Fish Revocable Trust increased to 479,194 shares. His direct holdings now total 435,456 shares, while an additional 300,000 shares are held indirectly through the Lorax Charitable Remainder Unitrust. The filing does not specify Wilson’s motivation for the transaction.
